ICU and 1-year mortality rate were 56 and 77%, respectively (Table 3).
After scheduled surgery, the ICU and hospital mortality rate were 12 and 25%%, respectively [9].
The cesarean delivery rate and the neonatal mortality rate were calculated for each year.
Effects of temperature, sunlight irradiation and settlement on the mortality rate were measured.
However, feed intake and mortality rate were only increased (P < 0.05) in the acute heat stress treatment.
Comorbid factors, duration of surgery, duration of hospitalisation, complications, walking ability, time to union and mortality rate were recorded.
ICU length of stay and ICU mortality rate were compared with the same time period previous to AMS implementation.
The multivariate analysis also revealed that the factors independently associated with a higher in-ICU mortality rate were age (P = 0.02) and norepinephrine dose (P = 0.0001).
Demographic characteristics, risk factors, need and type of mechanical ventilatory support, laboratory values, need of extracorporeal pulmonary (ECMO) and renal support (CRRT) and mortality rate were evaluated.
More favourable results (∼10% 1-month mortality rate) were encountered for patients with refractory vasospasm complicating subarachnoid haemorrhage or intracerebral haemorrhage complicating supratentorial arteriovenous malformation resection.
The multivariate analysis also revealed that the factors independently associated with a higher mortality rate were a higher age (P = 0.02) and a higher norepinephrine dose (P = 0.0001) (Table 5).
